What to Know About Biologics for Psoriasis
A Newer Treatment Option

There are newer treatment options for psoriasis.

One of the newer treatments for moderate to severe psoriasis and psoriatic arthritis is a group of medications known as biologics. Biologics are made from proteins produced by living cells in a laboratory. Here's what you should know about these medications and how they may be able to help your psoriasis.

Was this helpful? (19)

Medically Reviewed By: William C. Lloyd III, MD, FACS | Last Review Date:

© 2018 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.

View Sources

Medical References

  1. Cheng J, Feldman SR. The cost of biologics for psoriasis is increasing. Drugs in Context 2014; 3: 212266. doi: 10.7573/ dic.212266. http://www.drugsincontext.com/cost-biologics-psoriasis-increasing/
  2. Ferrándiz C, et. al. Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology. 2012;26(6):768-777. 
  3. Smith CH, et al. British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. British Journal of Dermatology. 2009;161:987–1019. 
  4. FDA Drug Safety Communication: UPDATE on Tumor Necrosis Factor (TNF) blockers and risk for pediatric malignancy. U.S. Food and Drug Administration. http://www.fda.gov/drugs/drugsafety/ucm278267.htm
  5. Questions and Answers about Psoriasis. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. http://www.niams.nih.gov/Health_Info/Psoriasis/
  6. Psoriasis: Biologics. American Academy of Dermatology. https://www.aad.org/practicecenter/quality/clinical-guidelines/psoriasis/biologics